Physician profile
Alexander Roth
NPI 1992237580
$8,551.59
in general payments reported to CMS, 2019-2025
10 companies · $1,219 in 2025
The $1,219 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $104 · 2022: $3,385 · 2023: $2,958 · 2024: $886 · 2025: $1,219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,602 · Travel and Lodging: $1,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,602.03 |
| Travel and Lodging | $1,460.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,759.92 | 2022-2025 | Mako, Accolade, Insignia |
| Zimmer Biomet Holdings, INC. | $1,785.57 | 2022-2025 | Persona, Rosa, Oxford |
| Medtronic, INC. | $222.31 | 2022-2025 | Aquamantys(Tm) |
| Davol INC. | $158.44 | 2025 | Arista |
| Biocomposites INC | $134.68 | 2023 | Stimulan |
| Orthalign INC | $134.55 | 2024 | Orthalign Plus |
| Onkos Surgical, INC. | $124.60 | 2025 | Eleos Limb Salvage System |
| Depuy Synthes Sales INC. | $112.96 | 2022-2024 | Va-Lcp, Na, Tfn-Advance |
| Osteomed LLC | $103.68 | 2020 | |
| Bioventus LLC | $14.88 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.